Whether youre actively losing weight or maintaining results, this approach can help you achieve a more defined, toned physique without surgery
Summary: In a Diabetes Care randomized trial, Semaglutide significantly improved insulin sensitivity, reduced insulin resistance, lowered fasting glucose, and promoted substantial weight loss in patients with antipsychotic-induced metabolic disturbances
The company expects to potentially seek FDA approval sometime in late 2027 or early 2028
Dulaglutide and semaglutide also demonstrated positive effects on these proteins, though fewer studies were available
Many patients lose 1020% of their body weight while also improving: Blood sugar regulation Appetite control Blood pressure Overall metabolic health At Be Well Medical Group, we prescribe FDA-approved GLP-1 medications when appropriate and tailor treatment based on your goals, response, and tolerance